Fundraising Foxクリングルファーマ㈱
Osaka, JP · 4 known investors
Find your way into クリングルファーマ㈱
Sign up to see every warm intro you have to クリングルファーマ㈱
- Paths you didn't know you had: your email and LinkedIn already hold routes to the クリングルファーマ㈱ team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Kringle Pharma develops and manufactures HGF protein-based pharmaceuticals for treating conditions including spinal cord injury, ALS, and vocal cord scarring. The company is a spin-out of Osaka University and Keio University focused on drug development in the biotech sector.
Founders & leadership
TN
Toshikazu Nakamura
安
安達喜一
Investors · 4
Frequently asked questions
- What does クリングルファーマ㈱ do?
- Kringle Pharma develops and manufactures HGF protein-based pharmaceuticals for treating conditions including spinal cord injury, ALS, and vocal cord scarring. The company is a spin-out of Osaka University and Keio University focused on drug development in the biotech sector.
- Who founded クリングルファーマ㈱?
- クリングルファーマ㈱ was founded by Toshikazu Nakamura.
- Who are クリングルファーマ㈱'s investors?
- クリングルファーマ㈱'s investors include Chishima Real Estate — Startup Investment, DBJ Capital, OSAKA University Venture Capital, TOHOKU University Venture Partners.
- Where is クリングルファーマ㈱ headquartered?
- クリングルファーマ㈱ is headquartered in Osaka, JP.